Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll

December 28, 2012

Biotech Industry Forecast

The biotech industry experienced its share of stormy weather this year, from budget cuts and the fiscal cliff to Prometheus v. Mayo and a drop in VC funds, but there were a few sunny days here and there: FDA finally issued its draft guidance on the development and approval of biosimilar drugs, and two new obesity drugs were approved by FDA, the first in more than a decade. (For more on all of the above developments, click here.) So, what does your industry forecast look like for 2013—clear sailing ahead, or should sailors take warning?

What kind of future do you predict for the biotech industry in 2013?

  {{ choice.Percent }}%